Tempus AI's Q4 financials were slightly below expectations but aligned with preliminary results, presenting a buying ...

We recently published a list of 10 AI News and Ratings You Should Not Miss. In this article, we are going to take a look at ...

There's still plenty of time for growth investors to click the buy button on Tempus AI stock; however, it's critical to ...

Tempus AI (NASDAQ: TEM) rocketed from about 44% higher. All on news it just acquired Ambry Genetics, a well-known leader in ...

Tempus AI's slowing growth, cash flow issues, and net debt raise doubts about its sustainability. Explore key concerns and ...

Tempus AI Inc (NASDAQ:TEM) shares are trading lower Tuesday after the company reported mixed fourth-quarter financial results ...

Tempus announced its acquisition of Ambry Genetics at closing in November and the deal closed earlier this month.

Despite filing a fourth-quarter and yearend 2024 earnings report that the CEO described as "fantastic" yesterday afternoon, ...

Tempus AI Inc (TEM) reports impressive revenue growth, strategic acquisitions, and extended partnerships, setting the stage for a promising 2025.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today reported financia ...

Would you like to be notified of the latest news and updates on the stock market?

Tempus AI (TEM) lies at the core of the healthcare revolution. It uses AI to turn medical data into practical insights to ...